Noah Berkowitz - 18 Mar 2026 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Reporting relationship: Chief Medical Officer
Issuer ticker: ARVN
Reported as of: 18 Mar 2026
Net transaction value: -$71,431
SEC form: 4
Accepted by SEC: 19 Mar 2026, 20:01:54 UTC
Prior SEC filing: 02 Mar 2026
Next SEC filing: 13 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Jared Freedberg, as attorney-in-fact for Noah Berkowitz

Key filing fact

Noah Berkowitz filed Form 4 for ARVINAS, INC. (ARVN) on 19 Mar 2026.

Key facts

This page summarizes Noah Berkowitz's Form 4 filing for ARVINAS, INC. (ARVN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Mar 2026, 20:01.

Change

Previous filing in this sequence was filed on 02 Mar 2026.
Current net transaction value: -$71,431.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001369900 Primary reporting owner

Berkowitz Noah

Relationship: Chief Medical Officer
Address: C/O ARVINAS, INC., 5 SCIENCE PARK, 395 WINCHESTER AVE., NEW HAVEN
Signature: /s/ Jared Freedberg, as attorney-in-fact for Noah Berkowitz
Signature date: 19 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARVN transaction

Common Stock

Sale

Transaction value: $71,431
Shares: -6,435
Change %: -3.1%
Price: $11.10
Shares after: 202,503
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on March 18, 2024. The sale does not represent a discretionary trade.